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A polypeptide domain of molecular mass near 22 kDa was purified from CNBr-digest of iodine poor human 
thyroglobulin (hTgb). This fragment represents he N-terminal part of the hTgb molecule and consequently 
contains the preferential hormonogenic tyrosine 'acceptor' of the protein. This fragment could correspond 
to the non-iodinated and unreduced form of the thyroxinyl-containing 26 kDa peptide previously purified 
from reduced and iodinated hTgb. This 22 kDa fragment is capable by itself, i.e. independently of the re- 
maining hTgb molecule, of synthesizing thyroxine with a high efficiency after in vitro iodination. Its study 
should constitute a valuable way to identify at least one of the hormonogenic tyrosine "donor' residues of 
hTgb. 
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1. INTRODUCTION 
Thyroglobulin (Tgb), the dimeric glycoprotein 
(2 x 330 kDa) of the thyroid gland, is the support 
of thyroid hormone synthesis, T4 and T3. In the 
course of hormone formation, the coupling of two 
iodotyrosine residues results in the fission of one 
of them next to its aromatic ring and the 
iodophenolic moiety of the iodotyrosine residue 
which undergoes fission (donor) is transferred to 
the other iodotyrosine residue (acceptor). Recent 
knowledge of the primary structure of Tgb [1-3] 
and of the amino acids flanking the thyroid hor- 
mone residues in the mature protein made possible 
the precise enumeration and localization of the 
hormone forming (acceptor) sites of Tgb [4-7]. In 
contrast the position of the iodotyrosine donor 
residues remains elusive. It is evident that the 
spatial alignment, the distance and the orientation 
of the interacting tyrosine residues (acceptor and 
donor) are the most important factors. 
Recently the hypothesis that the Tgb molecule is 
arranged in a domain-like structure and that both 
hormonogenic tyrosine residues (acceptor + 
donor) are located in a self-contained omain 
which may be functionally independent of the re- 
maining sequence has been suggested [8]. 
In this report we describe the isolation of a hor- 
monogenic domain from human Tgb (hTgb); this 
fragment corresponding to the N-terminal part of 
the molecule contains the preferential hor- 
monogenic tyrosine residue acceptor of hTgb and 
is capable by itself of synthesizing T4 with high ef- 
ficiency after in vitro iodination. 
* To whom correspondence should be addressed 
Abbreviations: hTgb, human thyroglobulin; MIT, 
3-iodotyrosine; DIT, 3,5-diiodotyrosine; T4, thyroxine; 
T3, 3,5,3'-triiodothyronine 
2. MATERIALS AND METHODS 
2.1. Thyroglobulin preparation 
Poorly iodinated hTgbs were purified from col- 
loid goitres as in [9]. Very iodine-rich hTgb was 
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prepared from a poorly iodinated hTgb after in 
vitro iodination as in [7] using the amount of KI 
necessary to incorporate about 70 I atoms/mole- 
cule. The iodoamino acid composition of an iodine 
poor and an iodine rich hTgb is given in table 3. 
2.2. Cyanogen bromide (CNBr) cleavage 
For each preparation 300 mg hTgb were treated 
by CNBr as in [10]; the resulting CNBr-peptides 
were filtered onto a Sephadex G-200 column in 
1 M propionic acid. Each fraction was dialyzed 
against redistilled water and freeze-dried. 
2.3. In vitro iodination of 22 kDa species 
In a final volume of 500/A of 0.05 M Tris-HC1, 
pH 7.2, at 37°C were added 10 nmol 22 kDa 
species, 1 mg glucose, from 40 to 180 nmol KI and 
5/~g lactoperoxidase (Boehringer Mannheim, 
FRG). The reaction was initiated by 2.5/~g lucose 
oxidase (Boehringer) and stopped 30 min later by 
addition of NaHSO3. Excess iodide was eliminated 
by dialysis against redistilled water. Iodine incor- 
porated was estimated by iodoamino acid analysis 
after total enzymic hydrolysis as in [11]. A max- 
imal hormonosynthesis efficiency was obtained us- 
ing 14 nmol KI/nmol peptide. 
2.4. Disulfide bond estimation 
The number of disulfide bonds was calculated 
from the difference between total half-cystine 
residues estimated as carboxymethylcysteine 
residues after reduction and S-carboxymethylation 
and free cysteine residues measured after S- 
carboxymethylation without previous reduction. 
2.5. Other techniques 
Reduction and S-alkylation of 22 kDa species 
were performed as in [10] except hat the reagents 
were eliminated by Biogel P-2 filtration in 0.1 M 
ammonium bicarbonate. SDSoPAGE, amino acid 
and iodoamino acid analyses and N-terminal se- 
quence determination of peptides were carried out 
as described [4,12]. 
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Fig.1. Sephadex G-200 gel filtration of CNBr-treated 
iodine poor (A) and iodine rich (B) hTgb. 300 mg 
protein were layered onto a 2.6 × 90 cm column 
equilibrated and eluted with 1 M propionic acid. Flow 
rate, 6 ml/h; volume of fractions, 2 ml. Fractions were 
pooled according to arrowheads, to give fractions I-V. 
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3. RESULTS AND DISCUSSION 
3.1. Purification of 22 kDa species 
The elution profile of Sephadex G-200 gel filtra- 
tion (fig.l) of CNBr-cleaved iodine poor (A) and 
Fig.2. SDS-PAGE of (lane a) fraction IV (see fig.lA) 
and (lane b) purified 22 kDa species before and (lane c) 
after reduction by 1 °7o dithiothreitol for 3 rain at 100°C. 
Proteins were analyzed in 15O7o gels. 
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very iodine-rich (B) hTgb was different: indeed, in 
A fraction IV was higher and, inversely, fraction I
(containing heavier material) lower than in B. 
These results suggest hat a part of protein material 
from fraction IV shifted towards fraction I after 
iodination and hormonosynthesis. Qualitatively 
the same species were found in fraction IV 
whatever the origin of hTgb (poorly iodinated or 
very iodine-rich hTgb); SDS-PAGE revealed essen- 
tially a group of bands with molecular masses near 
45 kDa and a 22 kDa species (fig.2). In an attempt 
to purify further the 22 kDa component, material 
in fraction IV was applied on a Biogel A-0.5m col- 
umn and eluted with 0.1 M ammonium bicar- 
bonate. The 22 kDa component was obtained with 
small amounts of  a lighter species; in spite of a new 
filtration on Biogel P-30 this contaminant could 
not be quite eliminated. 
3.2. Characterization of 22 kDa species 
After reduction of  the 22 kDa component,  SDS- 
PAGE showed (fig.2) 4 new bands of molecular 
masses near 26, 22, 16 and 14 kDa. So, a 22 kDa 
species purified from CNBr-treated iodine poor 
hTgb was submitted to N-terminal sequence 
analysis: two residues with small amounts of  a 
third one were unambiguously identified at almost 
each step (table 1, row I). From these results, the 
three deduced amino acid sequcnces perfectly 
agreed with: (i) the N-terminal sequence of  hTgb; 
(ii) the amino acid sequence located after the 
methionine residue 127 and (iii) the sequence after 
the methionine 184 (fig.3). 
In table 2 the amino acid composit ion of the 
22 kDa species is compared with that of the 
26 kDa hormonopeptide previously purified from 
iodinated, fully reduced and S-alkylated hTgb 
Table 1 
Micro-sequencing of 22 kDa species 
Degradation steps 
No.: 1 2 3 4 5 6 
I 22 kDa species from Asn Ile Phe Glu Tyr Gin 
iodine poor hTgb Glu Val Tyr Gly Thr Arg 
lie (tr) Phe (It) Asp Leu (tr) 
II 22 kDa species from Asn/Asp lie Phe Glu MIT/DIT/T4 
iodine rich hTgb Glu Val Tyr (tr) Gly Thr 
Ile (tr) Phe (tr) Asp (tr) 
III 22 kDa species from Asn/Asp lie Phe Glu DIT/T4 
iodine poor hTgb and Glu Val Tyr (tr) Gly 
after in vitro Ile (tr) Phe (tr) Asp (tr) 
iodination 
Micro-sequencing by technique of Chang et al. [12]; tr, traces 
1 Asn- I~e-~he-G~u-T ; r -G~n-Va~-Asp-A la -G~n-P~-Le~-Arg -~r~-Cys -G~u-Leu-G~n-Ar~-G~u-Thr -A~a-~he-Leu-Lys -G ln -A la -Asp~yr~Va 1 _ 
31 Pro-Gl n-Cys-Ala-Glu-Asp-Gly-Ser-Phe-Gln-Thr-Val-Gln-Cys-GI n-Asn-Asp-Gly-Arg-Ser-Cys-Trp-Cys-Val-~|y-Ala-Asn-Gl y-Ser-Glu- 
61 Va•-Leu-G•y-Ser-Arg-Gln-Pr•-G•y-Arg-Pr•-Val-Ala-Cys-Leu-Ser-Phe-Cys-Gln-Leu-Gln-Lys-Gln-G•n-Ile-Leu-Leu-Ser-Gly•Tyr-I•e- 
91 Asn-Ser-Thr-Asp-Thr-Ser-Tyr-Leu-Pr•-Gln-Cys-G•n-Asp-Ser-Gly-Asp-Tyr-A•a-Pr•-val-Gln-cys-Asp-Val-Gln-His-Val-Gln•Cys-Trp- 
121 Cys-Va~-Asp-Ala-Glu~G~y~Me~G~u-val-Tyr-Gly-Thr~Arg-Gln-Leu-G~y-Arg-Pr~-Lys-Arg-Cys-Pr~-Arg-Ser-Cys-Glu~Ile-Arg-Asn-Arg- 
151 Arg-Leu~Leu-~is-Gly-va1-Gly-Asp-Lys-Ser-Pr~-Pr~-G1n-Cys-Ser-A1a-Glu~G~y-Glu-~heM~Pr~-Val-Gln-Cys-Lys-Phe-Va~Asn-Thr- 
181 Thr-Asp~le-Phe-Asp-Leu-Val-Hi~-Ser-Tyr-Asn-Arg-Phe-Pr~-Asp'A~a-~he-Val-Thr-Phe-~er-Ser-Phe-Gln-Arg-Arg-Phe-Pr~- 
211 G•u-Va•-Ser-Gly-Tyr-•ys-Hi•-•ys-A•a-Asp-Ser-G•n-G•y-Arg-Glu-Leu-Ala`Glu-Thr-Gly-Leu-G•u-Le•-Leu-Leu-Asp-Glu-Ile-Tyr-Asp- 
241 Thr -• le -•he-• la -G ly -Leu-Asp-Leu-Pr• -•er -Thr -Phe-Thr -G•u-Thr -Thr -Leu•Tyr -Arg-• le -  
Fig.3. Sequence of the first 260 amino acids from the N-terminal end of mature hTgb as deduced from the nucleotide 
sequence of its mRNA according to Matthiery and Lissitzky [2]. The tyrosine residue in position 5 (.) is the 
hormonogenic residue (acceptor) described [7]. Methionine residues are boxed. 
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Table 2 
Comparison of the 22 kDa species amino acid 
composition with that of the 26 kDa hormonopeptide 
22 kDa 26 kDa 
species a hormonopeptide 
according to 
Lejeune Dunn 
et al. [7] et al. [131 
Carboxymet hylcysteine ° 14.2 12.6 11.0 
Aspartic acid 21.3 18.0 23.3 
Threonine 9.1 7.1 10.7 
Serine 18.7 15.3 15.9 
Glutamic acid 40.7 37.8 39.6 
Proline 12.3 12.1 12.9 
Glycine 21.0 16.5 18.3 
Alanine 14.6 14.0 19.8 
Cysteine ~ 0.6 
Valine 16.5 16.2 18.8 
Methionine 1.2 2.2 1.7 
Isoleucine 6.0 6.1 6.7 
Leucine 18.8 16.3 17.6 
Tyrosine 5.9 6.4 3.8 
Phenylalanine 10.2 8.2 10.2 
Histidine 2.6 1.9 5.0 
Lysine 7.3 5.1 11.4 
Arginine 11.8 8.8 11.4 
Tryptophan nd nd nd 
a Average of analyses from 6 separate preparations of 
22 kDa species 
b Determined after reduction and S-carboxymethylation 
Determined as carboxymethylcysteine after S- 
carboxymethylation without previous reduction (see 
section 2.4) 
Results expressed as residue/tool peptide, all amino acid 
compositions were calculated assuming a molecular 
mass of 26 kDa; nd, not determined 
and unreduced form of 26 kDa hormonopeptide. 
However it is difficult to affirm this latter 
hypothesis since the C-terminal sequence has never 
been clearly identified either in the 26 kDa [14] or 
22 kDa (not shown). 
The N-terminal amino acid sequence of hTgb 
shown in fig.3 contains everal methionyl bonds. 
In 22 kDa species some of them are partially (or 
totally) cleaved by CNBr and the derived CNBr- 
peptides are disulfide bonded. Indeed nearly all of 
the half-cystine residues contained in 22 kDa (table 
2) are involved in disulfide bonds. So, after reduc- 
tion 22 kDa gives rise to several peptides (fig.2, 
lane c), among which 26 kDa could represent the 
reduced and consequently unfolded form of the 
uncleaved 22 kDa fragment; indeed as previously 
described for several proteins rich in disulfide 
bonds [15,16] the shift in molecular mass after 
reduction results from the unfolding of disulfide 
bonded internal domains leading to an apparent 
increase of chain length. 
3.3. Hormonosynthesis in 22 kDa species 
When 22 kDa was purified from very iodine-rich 
hTgb, it contained 0.51 mol T4/mol peptide (table 
3) and at the fifth step of recurrent degradation 
MIT, DIT and T4 were identified (table 1, row II). 
In contrast, when purified from iodine poor hTgb, 
22 kDa contained small amounts of MIT, traces of 
DIT and no T4; but after in vitro iodination under 
optimal conditions (see section 2.3) it is capable of 
synthesizing T4 with efficiency (table 3). In addi- 
Table 3 
Iodoamino acid composition of iodine poor (hTgb A), 
iodine rich (hTgb B) human thyroglobulin and their 
derived 22 kDa species 
[7,13]. It has been shown that this hormonopeptide 
represents the N-terminal part of the hTgb 
molecule and contains at the fifth position from 
the N-terminal asparagine residue (fig.3) the 
preferential hormonogenic tyrosine acceptor of 
hTgb [7]. When the amino acid composition of 
22 kDa species was calculated on the basis of a 
molecular mass of 26 kDa, both compositions 
agreed reasonably well. 
Taking into account hese results, it is likely that 
the 22 kDa represents he N-terminal part of hTgb; 
moreover it could correspond to the non-iodinated 
MIT DIT T3 T4 
hTgb A 2.82 0.28 0 tr 
22 kDa from hTgb A" 0.40 tr 0 0 
22 kDa from hTgb A a after 
in vitro iodination 0.70 1.10 0 0.23 
hTgb B 27.5 17.8 0 2.0 
22 kDa from hTgb B 0.60 1.10 0 0.51 
" Average of 6 separate xperiments 
Results expressed as residue/mol, determined assuming 
a molecular mass of 660 kDa for hTgb and 26 kDa for 
22 kDa species; tr, traces 
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tion after micro-sequencing of the in vitro 
iodinated 22 kDa, DIT and T4 were identified at 
the fifth step (table 1, row III). It is obvious that 
in the course of the coupling reaction which occurs 
either in 22 kDa peptide or in the whole hTgb 
molecule the same tyrosine residue acceptor is in- 
volved in T4 synthesis. In spite of the partial 
cleavage of some (methionyl or others) bonds in 
the 22 kDa, it is possible that this fragment owing 
to its high degree of cross-linkage (about 7 
disulfide bonds; table 2) has retained an ap- 
preciable part of the three-dimensional native con- 
formation allowing this hormonogenic domain to 
synthesize T4 in vitro with efficiency. 
The localization of the tyrosine residue donor in- 
volved in T4 formation in this domain is the aim of 
our present investigations. 
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